Short Interest in iCoreConnect Inc. (NASDAQ:ICCT) Rises By 450.1%

Posted by James Quigley on Mar 12th, 2025

iCoreConnect Inc. (NASDAQ:ICCT – Get Free Report) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 254,700 shares, a growth of 450.1% from the February 13th total of 46,300 shares. Based on an average daily volume of 1,010,000 shares, the days-to-cover ratio is currently 0.3 days. Currently, 18.1% of the company’s shares are sold short.

Institutional Trading of iCoreConnect

An institutional investor recently bought a new position in iCoreConnect stock. Virtu Financial LLC bought a new position in iCoreConnect Inc. (NASDAQ:ICCT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 12,698 shares of the company’s stock, valued at approximately $32,000. Virtu Financial LLC owned approximately 1.04% of iCoreConnect as of its most recent filing with the SEC. Institutional investors and hedge funds own 13.42% of the company’s stock.

iCoreConnect Trading Down 2.1 %

Shares of NASDAQ:ICCT traded down $0.02 on Wednesday, hitting $0.71. The company had a trading volume of 818,891 shares, compared to its average volume of 321,980. The firm’s 50-day simple moving average is $2.03 and its two-hundred day simple moving average is $4.55. The firm has a market capitalization of $1.48 million, a price-to-earnings ratio of -0.01 and a beta of 1.09. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 7.93. iCoreConnect has a 1 year low of $0.61 and a 1 year high of $35.80.

iCoreConnect Company Profile

(Get Free Report)

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.